Comment on FR Doc # 2012-25509

Document ID: DEA-2012-0006-0007
Document Type: Public Submission
Agency: Drug Enforcement Administration
Received Date: October 31 2012, at 12:20 PM Eastern Daylight Time
Date Posted: November 2 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: October 17 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: December 17 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 1jw-81ps-h7lv
View Document:  View as format xml

View Comment

Methylone seems to be a dangerous drug. The important word in that sentence is “seems.” The event in Florida with a man eating a person’s face because he was “high on bath salts” (later confirmed to be methylone) is a shocking and surprising news story. But policy cannot be made on singular, albeit appalling, news events. The role of the DEA along with the FDA should be to protect the American people from dangerous drugs, but allow drugs with medical purposes to be allowed to the public. It seems that the correct way to follow these procedures is not to issue “emergency” rulemakings based on recent hyperbolic news events about Florida turning into a state of zombies based on one demented person. Methylone could very well have no medical use and should therefore correctly be classified as a Schedule I drug, but the full extent of medical tests have not been performed. Methylone is closely related to MDMA. MDMA, extasy, and its subsidiaries have long been shown to have some type of correlation in therapy with a much quicker solution to long running anti-depression drugs. Doctors have tried creating a drug close to MDMA that does not result in the “high” that it is used on the street for, but still has the immediate anti-depression response. Perhaps methylone could be one of the next steps to finding that drug. It is likely that methylone would prove to have no medical use; however, that decision should be made by the medical community, and not the Dawn of the Dead community.

Related Comments

    View All
Total: 15
Comment on FR Doc # 2012-25509
Public Submission    Posted: 11/02/2012     ID: DEA-2012-0006-0005

Dec 17,2012 11:59 PM ET
Comment on FR Doc # 2012-25509
Public Submission    Posted: 11/02/2012     ID: DEA-2012-0006-0006

Dec 17,2012 11:59 PM ET
Comment on FR Doc # 2012-25509
Public Submission    Posted: 11/02/2012     ID: DEA-2012-0006-0007

Dec 17,2012 11:59 PM ET
Comment on FR Doc # 2012-25509
Public Submission    Posted: 11/02/2012     ID: DEA-2012-0006-0008

Dec 17,2012 11:59 PM ET
Comment on FR Doc # 2012-25509
Public Submission    Posted: 11/02/2012     ID: DEA-2012-0006-0009

Dec 17,2012 11:59 PM ET